OpenAI Acquires AI Personal Finance Startup Hiro
OpenAI has acquired AI-driven personal finance startup Hiro, marking its 15th acquisition in the past year and expanding its financial technology capabilities.
Key Points
- OpenAI acquired AI personal finance startup Hiro, its 15th acquisition in a year.
- Hiro's AI-powered personal CFO tool launched five months ago.
- The acquisition expands OpenAI's capabilities in financial technology.
Full Details
OpenAI has completed the acquisition of Hiro, a U.S.-based AI personal finance fintech, as reported by FinTech Futures and TechCrunch. Founded in 2024 by co-CEOs Ethan Bloch and Rushabh Doshi, Hiro launched an AI-powered personal CFO tool five months ago. This acquisition represents OpenAI's 15th purchase in the past year, signaling an aggressive expansion into the fintech space. The move aims to embed advanced financial-management capabilities into OpenAI's services, enhancing its AI offerings. Hiro's tool is designed to provide AI-driven personal financial assistance, aligning with OpenAI's broader strategy to integrate AI into various sectors.
Why It Matters
This acquisition highlights OpenAI's aggressive expansion into fintech and could accelerate the integration of AI into personal finance management.
Get stories like this delivered daily
AI-curated news, personalized to your interests. Zero noise.
Start 7-Day Free Trial →More in Artificial Intelligence
Nvidia AI Chip Rivals Attract Record Funding as Competition Intensifies
Emerging AI chip startups challenging Nvidia's dominance are attracting unprecedented levels of investment as competition heats up in the semiconductor sector.
Cursor AI Startup in Talks for $2 Billion Funding at $50 Billion Valuation
AI coding-agent startup Cursor is negotiating a $2 billion funding round at a valuation exceeding $50 billion, highlighting intense venture capital interest in AI development tools.
Yann LeCun's AMI Labs Secures Over $1 Billion for AI World Models Development
AMI Labs, founded by AI pioneer Yann LeCun, has raised more than $1 billion to develop 'world models' - a new AI approach that teaches systems to understand inputs conceptually rather than as isolated components.
AI Revolutionizes Drug Target Identification and Assessment in Pharmaceutical Research
Artificial intelligence is playing an increasingly critical role in drug target identification and assessment, with new machine learning approaches transforming how researchers discover therapeutic targets for diseases including cancer, aging, and Alzheimer's.